Cannabis Bioscience International Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBIH research report →
Price Chart
About the company
China Infrastructure Construction Corp. delivers specialized education focusing on medical cannabis to audiences in the United States and Latin America, while also reaching a global market through its online programs. The company further extends its services to therapeutic areas, including supporting clinical trials and offering focused treatment for sleep disorders, specifically those linked to infertility, all managed through its fertility and sleep center located in Houston, Texas.
- CEO
- Dante Picazo
- IPO
- 2023
- Employees
- 2
- HQ
- Houston, TX, US
Get TickerSpark's AI analysis on CBIH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.16M
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 9.40
- P/B
- -0.79
- EV/EBITDA
- -5.17
- Div Yield
- 0.00%
- Gross Margin
- -0.06%
- Op Margin
- -312.80%
- Net Margin
- -416.81%
- ROE
- 39.33%
- ROIC
- 36.45%
Latest fiscal year · YoY change
- Revenue
- $303.02K+21.8%
- Gross Profit
- $262.92K+29.4%
- Op Income
- $-421,365
- Net Income
- $-548,820+15.7%
- EPS
- $-0.05+18.9%
- OCF Growth
- +31.2%
- FCF Growth
- +31.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.41
- RSI (14)
- 55
- Avg Volume
- 3.49M
No earnings-call transcripts are available for CBIH yet.
- Free Float
- 41.6%
- Shares Outstanding
- 11.63B
- Float Shares
- 4.84B
Our CBIH coverage
Recent articles, reports, and earnings notes.
No research on CBIH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBIH report →CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings
feeds.newsfilecorp.com · Jul 6
Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement
newsfilecorp.com · Jun 22
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
newsfilecorp.com · Jun 15
CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers
feeds.newsfilecorp.com · Jun 8
CBIH Completes Cannabinoid-Based Melanoma Patent Application Program Focused on Cannabinoid Science and Epigenetic Regulation
feeds.newsfilecorp.com · Jun 1
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
feeds.newsfilecorp.com · Jan 12
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
feeds.newsfilecorp.com · Dec 29
CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities
feeds.newsfilecorp.com · Dec 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.